Cargando…
Update on Minimalist TAVR Care Pathways: Approaches to Care in 2022
PURPOSE OF REVIEW: This review summarizes current data supporting a minimalist TAVR approach and identifies the need for additional study to optimize TAVR care. The authors discuss future directions of the TAVR landscape and how this necessitates evolution of minimalist care pathways. RECENT FINDING...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244066/ https://www.ncbi.nlm.nih.gov/pubmed/35767177 http://dx.doi.org/10.1007/s11886-022-01737-x |
_version_ | 1784738442564861952 |
---|---|
author | Sawan, Mariem A. Calhoun, Avery E. Grubb, Kendra J. Devireddy, Chandan M. |
author_facet | Sawan, Mariem A. Calhoun, Avery E. Grubb, Kendra J. Devireddy, Chandan M. |
author_sort | Sawan, Mariem A. |
collection | PubMed |
description | PURPOSE OF REVIEW: This review summarizes current data supporting a minimalist TAVR approach and identifies the need for additional study to optimize TAVR care. The authors discuss future directions of the TAVR landscape and how this necessitates evolution of minimalist care pathways. RECENT FINDINGS: Transcatheter aortic valve replacement (TAVR) has become a mainstay in the treatment of aortic stenosis since the initial procedure in 2002. Recently, attention has shifted to TAVR optimization and the minimalist approach with a focus on minimizing procedural sedation, protocolization of perioperative management, and prioritization on early discharge. This approach has been shown to be safe and reduce procedure time, length of stay, and overall cost for hospital systems. SUMMARY: The minimalist care pathway avoids general anesthesia, shortens procedure time and length of stay, and reduces cost without changing mortality or readmission rates at 30 days. A variety of protocols have been proposed without a clear consensus on specific components or patient eligibility. There is a continued need for data regarding patient risk stratification, valve selection, and discharge strategy as TAVR becomes increasingly common. |
format | Online Article Text |
id | pubmed-9244066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-92440662022-06-30 Update on Minimalist TAVR Care Pathways: Approaches to Care in 2022 Sawan, Mariem A. Calhoun, Avery E. Grubb, Kendra J. Devireddy, Chandan M. Curr Cardiol Rep Valvular Heart Disease (TL Kiefer, Section Editor) PURPOSE OF REVIEW: This review summarizes current data supporting a minimalist TAVR approach and identifies the need for additional study to optimize TAVR care. The authors discuss future directions of the TAVR landscape and how this necessitates evolution of minimalist care pathways. RECENT FINDINGS: Transcatheter aortic valve replacement (TAVR) has become a mainstay in the treatment of aortic stenosis since the initial procedure in 2002. Recently, attention has shifted to TAVR optimization and the minimalist approach with a focus on minimizing procedural sedation, protocolization of perioperative management, and prioritization on early discharge. This approach has been shown to be safe and reduce procedure time, length of stay, and overall cost for hospital systems. SUMMARY: The minimalist care pathway avoids general anesthesia, shortens procedure time and length of stay, and reduces cost without changing mortality or readmission rates at 30 days. A variety of protocols have been proposed without a clear consensus on specific components or patient eligibility. There is a continued need for data regarding patient risk stratification, valve selection, and discharge strategy as TAVR becomes increasingly common. Springer US 2022-06-29 2022 /pmc/articles/PMC9244066/ /pubmed/35767177 http://dx.doi.org/10.1007/s11886-022-01737-x Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Valvular Heart Disease (TL Kiefer, Section Editor) Sawan, Mariem A. Calhoun, Avery E. Grubb, Kendra J. Devireddy, Chandan M. Update on Minimalist TAVR Care Pathways: Approaches to Care in 2022 |
title | Update on Minimalist TAVR Care Pathways: Approaches to Care in 2022 |
title_full | Update on Minimalist TAVR Care Pathways: Approaches to Care in 2022 |
title_fullStr | Update on Minimalist TAVR Care Pathways: Approaches to Care in 2022 |
title_full_unstemmed | Update on Minimalist TAVR Care Pathways: Approaches to Care in 2022 |
title_short | Update on Minimalist TAVR Care Pathways: Approaches to Care in 2022 |
title_sort | update on minimalist tavr care pathways: approaches to care in 2022 |
topic | Valvular Heart Disease (TL Kiefer, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244066/ https://www.ncbi.nlm.nih.gov/pubmed/35767177 http://dx.doi.org/10.1007/s11886-022-01737-x |
work_keys_str_mv | AT sawanmariema updateonminimalisttavrcarepathwaysapproachestocarein2022 AT calhounaverye updateonminimalisttavrcarepathwaysapproachestocarein2022 AT grubbkendraj updateonminimalisttavrcarepathwaysapproachestocarein2022 AT devireddychandanm updateonminimalisttavrcarepathwaysapproachestocarein2022 |